Content area
Full Text
This is the fourth of an occasional series on the methods of randomised controlled trials
When patients do not receive their preferred treatment in randomised trials there may be difficulties with patient recruitment and scientific problems with bias. 1 For example, bias may occur when patients are aware of a new treatment not available to them and comply poorly with the standard treatment.
Zelen's design can address these difficulties 2 3 by randomising patients before consent to participate has been sought. Two types of the design exist: double and single consent. In the double consent version patients are initially offered the treatment to which they were randomised; however, if they decline the randomised treatment, they can then be offered alternative therapies-including the experimental treatment. In the single consent version only patients offered the experimental treatment are told there is an alternative treatment (the control) available. Patients randomised to the control treatment are not allowed the experimental treatment (although they are given unhindered access to any usual treatment facilities). Analysis is undertaken with patients retaining their original assignment.
Zelen's design has been much discussed and for most therapeutic trials is probably unethical. Occasionally, however, it has been chosen on ethical grounds. For example, in a trial of...